BNP Paribas Arbitrage Issuance BV (0GZD) Noticias

Crazy bullish potential!

Lakota, it sounded to me like a lot was said that needs to be examined. I was left wondering about tokens, new companies, and future growth. Lots that can be coming, from my reading between the lines. As you said, 2025 is just getting started!

I don’t know why I responded to you. I thought I had you on ignore. You’re too much work and my previous posts with you just left me bored and frustrated. There’s always two ways something can be interpreted. Yours is almost always negative. I see JetMek wearing himself out countering your rumors

If it is 2.5B market size for generic Vyvanse then still 10% of it is $250M revenue and if still $4.3B then 10% is way higher. So, regardless we will see $2 PPS by next year this time.

GLTA

Perfect, thanks!

So a U.S. government-supported financial institution specializing in global trade financing is backing the PROVEN AOT as per the FACTS in the RECENT PR below.


https://www.accesswire.com/959008/qs-energy-announces-milestones-in-global-sales-activity-and-strategic-partnerships-a

Pivot Calcs: SPX Pivot--5985----R1--6010----R2--6046----S1--5949----S2--5924-----SPY Pivot--596----R1--599----S1--592-----VIX Pivot--16.20 !!LOL!!

A Notice to the Board; The INQD / Indoor Harvest, Security Details was updated
again today at OTC Markets, Monday, January 6, 2025 !!!
Note: ( No change on the OS ) !!!

~ ( Could it be that Q 1, 2 & 3 will be out - SOON ? )

Note; INQD has been downgraded

https://investorshub.advfn.com/uimage/uploads/2025/1/6/dirggxrp_!_6_snip_10am_LOOK_AT_IT_GO.jpg



JAN 2nd
https://investorshub.advfn.com/uimage/uploads/2025/1/6/sfkzzxrp_!_2_30d_11pm_calvin.jpg




4 DAYS LATER.....
https:

I believe when you submit an NDA or BLA to the FDA they make the decision whether to treat it with priority review, or not. If you get a PDUFA that's 6 months after they accept it, they gave priority review.

I believe that Alzheimer's is a sufficiently serious problem that it will be

Poly-ICLC is not a complementary immunotherapy agent, it is a synergistic agent.

It is an immune-boosting agent, and it will be used to improve the formulation and potency of both DCVax-L and DCVax-Direct. Here is an excerpt from the NWBio 10-Q :

entered into a contrac

Proposal No. 1: Passed
65,138 votes for. 0 votes against

Proposal No. 2: This proposal was ratified
418k votes for Independent accounting firm

Proposal No. 3: non-binding resolution approving the compensation of the Company’s named executive officer - This

BIEL: +50% - BUY RATING
https://www.barchart.com/stocks/quotes/BIEL/opinion

BTW, what is full production. Maybe you can put a number to it? Jensen doesn't give out numbers.

Quester's trippin' on the first $1M payment is stupid. Bullheaded, intentional stupidity. Now that's commitment.

BIEL: +50% - BUY RATING
https://www.barchart.com/stocks/quotes/BIEL/opinion

ARBE. The magic words. Read the article in its entirety. This is awesome.

Your explanation as to why the stock went up today in anticipation and now it's dropping? Maybe you can explain why the stock dropped after a good Q and if the stock continues it's negative trend tomorrow. Maybe Jensen should give the analysts what they want to hear. Also Morningstar shows another d

BIEL: +50%, 911 NEWS PENDING!
https://recoveryrx1.carrd.co/

BIEL: +50%, 911 NEWS PENDING!
https://recoveryrx1.carrd.co/

Great post here... Please sticky

Read the magic words. Magic is waiting to happen.

https://investorshub.advfn.com/uimage/uploads/2025/1/6/wfrk%5BScreenshot_2025-01-06_at_10.17.16_PM.webp